 Challenges in Prostate Cancer, 2nd Edition
ISBN: 978-1-4051-0752-5
Hardcover
296 pages
June 2006, Wiley-Blackwell
US $149.95
 Add to Cart
This price is valid for United States. Change location to view local pricing and availability. Other Available Formats: Adobe E-Book
|
An online version of this product is available through our subscription-based content service. Visit Wiley InterScience now |
Part 1: Biological and Scientific Aspects.
1 An Update on Biotechnology in the Assessment of Prostate Cancer.
2 What Can We Learn From Breast Cancer?.
3 New Serum Markers for Prostate Cancer.
4 The History of Tissue Recombination Technology: Current and Future Research.
5 Why We Cannot Use the Results of Non-Randomised Trials to Inform Us About Treatment for Early Prostate Cancer?.
Part 2: Diagnosis and Evaluation.
6 Equivocal PSAResults and Free Total PSARatio.
7 Equivocal Prostate Needle Biopsies.
8 Prostate Biopsy: How Many Cores and Where From?.
9 Counselling Patients With Early Prostate Cancer.
10 The Role of Pelvic Node Dissection in Prostate Cancer.
Part 3: Initial Treatment Policies.
11 Laparoscopic Radical Prostatectomy.
12 Endocrine Therapy for Prostate Cancer: the Latest.
13 The Role of Conservative Policies in the Treatment of Prostate Cancer.
14 Complementary and Alternative Therapies for Prostate Cancer.
Part 4: Monitoring Progress and SecondaryTreatment.
15 Radical Prostatectomy After Radical Radiotherapy.
16 Treatment of Renal Impairment Secondary to Locally Advanced Prostate Cancer.
17 Open Radical Prostatectomy: How Can Intra-operative, Peri-operative and Post-operative Complications Be Prevented?.
18 Documenting Prostate Cancer: Epidemiology and Treatment.
19 Trends in Prostate Cancer Incidence and Mortality.
20 Chemotherapy in Prostate Cancer.
Index.
Colour plates
1 An Update on Biotechnology in the Assessment of Prostate Cancer.
2 What Can We Learn From Breast Cancer?.
3 New Serum Markers for Prostate Cancer.
4 The History of Tissue Recombination Technology: Current and Future Research.
5 Why We Cannot Use the Results of Non-Randomised Trials to Inform Us About Treatment for Early Prostate Cancer?.
Part 2: Diagnosis and Evaluation.
6 Equivocal PSAResults and Free Total PSARatio.
7 Equivocal Prostate Needle Biopsies.
8 Prostate Biopsy: How Many Cores and Where From?.
9 Counselling Patients With Early Prostate Cancer.
10 The Role of Pelvic Node Dissection in Prostate Cancer.
Part 3: Initial Treatment Policies.
11 Laparoscopic Radical Prostatectomy.
12 Endocrine Therapy for Prostate Cancer: the Latest.
13 The Role of Conservative Policies in the Treatment of Prostate Cancer.
14 Complementary and Alternative Therapies for Prostate Cancer.
Part 4: Monitoring Progress and SecondaryTreatment.
15 Radical Prostatectomy After Radical Radiotherapy.
16 Treatment of Renal Impairment Secondary to Locally Advanced Prostate Cancer.
17 Open Radical Prostatectomy: How Can Intra-operative, Peri-operative and Post-operative Complications Be Prevented?.
18 Documenting Prostate Cancer: Epidemiology and Treatment.
19 Trends in Prostate Cancer Incidence and Mortality.
20 Chemotherapy in Prostate Cancer.
Index.
Colour plates
